In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

But now, in a surprise twist, the team that earned the Nobel Prize in chemistry for developing CRISPR is asking to cancel two ...

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

Two Nobel Prize winners want to cancel their own CRISPR patents in Europe In the decade-long fight to control CRISPR, the ...

If you love investing in stocks you're bound to buy some losers. Long term CRISPR Therapeutics AG (NASDAQ:CRSP) shareholders ...

Despite a 65% stock drop since 2022, Intellia's advancements in Phase 3 trials and strong partnerships make NTLA stock a ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given Weill ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $45.92, marking a -1.86% move from the previous day.

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply ...

Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following ...

Hypothetically, if you controlled which DNA is stored in the CRISPR regions, you could manipulate the bacteria into inserting ...

A Shift In The Geomagnetic Field Has Distorted Measurements Of The Florida Current Kamala Harris Turns Biden's $493 Billion ...